Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
663 participants
OBSERVATIONAL
2017-09-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:
NCT05055895
Medication Repurposing to Stop Cognitive Decline in Dementia
NCT05817188
Cholinergic Health After Menopause (CHAMP)
NCT04129060
Cholinergic Mechanisms of Attention in Aging
NCT04756232
The Nicotinic Cholinergic System and Cognitive Aging
NCT03408574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Angelholm Hospital
OTHER
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Johansson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Region Skåne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Specialistminnesmottagningen
Ängelholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rube T, Ecorcheville A, Londos E, Modig S, Johansson P. Development of the Swedish anticholinergic burden scale (Swe-ABS). BMC Geriatr. 2023 Aug 25;23(1):518. doi: 10.1186/s12877-023-04225-1.
Related Links
Access external resources that provide additional context or updates about the study.
Article BMC Geriatr. 2023 Aug.25;23(1):518
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Studie ACB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.